SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 15-12G - Securities registration termination [Section 12(g)]:
SEC Accession No. 0001193125-24-149921
Filing Date
2024-05-30
Accepted
2024-05-30 09:12:26
Documents
1
Effectiveness Date
2024-05-30

Document Format Files

Seq Description Document Type Size
1 15-12G d835572d1512g.htm 15-12G 10212
  Complete submission text file 0001193125-24-149921.txt   11461
Mailing Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102
Business Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102 206-788-4545
ALPINE IMMUNE SCIENCES, INC. (Filer) CIK: 0001626199 (see all company filings)

IRS No.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 15-12G | Act: 34 | File No.: 001-37449 | Film No.: 241001268
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)